Lee Hyun, Choi Hayoung, Jo Yong Suk
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Front Med (Lausanne). 2022 May 3;9:870617. doi: 10.3389/fmed.2022.870617. eCollection 2022.
Influenza vaccination is strongly recommended for people with chronic lung diseases, including chronic obstructive pulmonary disease, to reduce risk of exacerbation. We assess the influenza vaccination rate and its related factors in participants with airflow limitation (AFL) using nationally representative data in Korea.
We conducted a cross-sectional study from the Korea National Health and Nutrition Examination Survey from 2007 to 2018. Individuals ≥ 40 years who underwent spirometry and had identifiable information on influenza vaccination status were included.
Overall influenza vaccination coverage was 61.2% in participants with AFL and 41.8% in participants without AFL. Age had a significant impact on the yearly vaccination rate in participants with AFL. Over the 10 years of study period, while the yearly vaccination rate steadily increased from 58.3 to 61.9% in elderly participants (≥65 years) with AFL ( for trend = 0.117), the yearly vaccination rate decreased from 41.5% to 30.8% in younger participants (<65 years) ( for trend = 0.038). In multivariable analyses, younger age [adjusted odds ratio (OR) for unvaccinated = 0.88, 95% confidence interval (CI) = 0.87-0.90], male (adjusted OR = 1.64; 95% CI = 1.23-2.19), and current smokers (adjusted OR = 1.42, 95% CI = 1.01-2.00) were associated with increased odds of being unvaccinated.
The vaccination rate in participants with AFL affected by age. Younger age, male sex, and current smoking were associated with unvaccinated status. More attention and targeted interventions are required to improve the influenza vaccination rate in those with AFL.
强烈建议患有慢性肺部疾病(包括慢性阻塞性肺疾病)的人接种流感疫苗,以降低病情加重的风险。我们使用韩国具有全国代表性的数据,评估气流受限(AFL)参与者的流感疫苗接种率及其相关因素。
我们对2007年至2018年韩国国家健康与营养检查调查进行了横断面研究。纳入年龄≥40岁且接受过肺活量测定并具有可识别流感疫苗接种状况信息的个体。
AFL参与者的总体流感疫苗接种覆盖率为61.2%,无AFL参与者为41.8%。年龄对AFL参与者的年度接种率有显著影响。在10年的研究期间,AFL老年参与者(≥65岁)的年度接种率从58.3%稳步上升至61.9%(趋势P=0.117),而年轻参与者(<65岁)的年度接种率从41.5%降至30.8%(趋势P=P0.038)。在多变量分析中,较年轻的年龄(未接种疫苗的调整优势比[OR]=0.88,95%置信区间[CI]=0.87-0.90)、男性(调整OR=1.64;95%CI=1.23-2.19)和当前吸烟者(调整OR=1.42,95%CI=1.01-2.00)与未接种疫苗的几率增加相关。
AFL参与者的疫苗接种率受年龄影响。较年轻的年龄、男性性别和当前吸烟与未接种疫苗状态相关。需要更多关注和有针对性的干预措施来提高AFL患者的流感疫苗接种率。